Subscription Now Possible to TBMed (A testing bed for the development of high-risk medical devices) Newsletter
It is now possible to subscribe to the TBMED (A testing bed for the development of high-risk medical devices) project newsletter. To do so, please click here.
TBMED aims to establish an open innovation testing bed specialised in the development of high-risk devices (≥Class IIb). It will provide an integral service to accelerate the development of medical devices reducing time to market, covering technology development from TRL4-7 based on Quality-by-Design (QbD) concept and business management services. QbD concept enhances product and process understanding together with process control, based on robust scientific knowledge and quality risk management. Four different medical devices will be used as case studies.
ECRIN is part of the TBMED consortium.
TBMED has received funding from the European Union Horizon 2020 programme under grant agreement number 825884.
